Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading
暂无分享,去创建一个
Tuomas P. J. Knowles | Christopher M. Dobson | Nicholas W. Wood | David Klenerman | Sonia Gandhi | Nunilo Cremades | C. Dobson | D. Klenerman | N. Wood | M. Horrocks | Kristina A. Ganzinger | T. Knowles | S. Gandhi | A. Abramov | N. Cremades | Marija Iljina | Gonzalo A. Garcia | Mathew H. Horrocks | Laura Tosatto | Minee L. Choi | Andrey Y. Abramov | Laura Tosatto | Marija Iljina | L. Tosatto
[1] C. Dobson,et al. Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson’s disease genetically related mutants , 2015, Scientific Reports.
[2] C. Dobson,et al. Fast flow microfluidics and single-molecule fluorescence for the rapid characterization of α-synuclein oligomers. , 2015, Analytical chemistry.
[3] Mathew H Horrocks,et al. A mechanistic model of tau amyloid aggregation based on direct observation of oligomers , 2015, Nature Communications.
[4] C. Dobson,et al. Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation , 2015, Proceedings of the National Academy of Sciences.
[5] C. Dobson,et al. Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation. , 2015, Nature chemical biology.
[6] Vivek K Unni,et al. Progressive aggregation of alpha-synuclein and selective degeneration of Lewy inclusion-bearing neurons in a mouse model of parkinsonism , 2015, Cell reports.
[7] A. Jeans,et al. Is Parkinson's Disease Truly a Prion-Like Disorder? An Appraisal of Current Evidence , 2015, Neurology research international.
[8] Thomas G. Beach,et al. Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry , 2014, Scientific Reports.
[9] Michele Vendruscolo,et al. Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation , 2014, Proceedings of the National Academy of Sciences.
[10] C. Dobson,et al. Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage , 2014, Biochemistry.
[11] C. Dobson,et al. Nucleation-conversion-polymerization reactions of biological macromolecules with prenucleation clusters. , 2014, Physical review. E, Statistical, nonlinear, and soft matter physics.
[12] Alexander K. Buell,et al. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. , 2014, Journal of the American Chemical Society.
[13] S. Jackson,et al. Hsp90 inhibits α-synuclein aggregation by interacting with soluble oligomers. , 2013, Journal of molecular biology.
[14] T. Yao,et al. Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains. , 2013, Molecular cell.
[15] D. Borchelt,et al. Thinking laterally about neurodegenerative proteinopathies. , 2013, The Journal of clinical investigation.
[16] Masato Hasegawa,et al. Prion-like spreading of pathological α-synuclein in brain , 2013, Brain : a journal of neurology.
[17] J. Trojanowski,et al. Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.
[18] S. Prusiner,et al. A Unifying Role for Prions in Neurodegenerative Diseases , 2012, Science.
[19] Christopher M. Dobson,et al. Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein , 2012, Cell.
[20] J. Trojanowski,et al. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice , 2012, The Journal of experimental medicine.
[21] Mathew H Horrocks,et al. Single molecule fluorescence under conditions of fast flow. , 2012, Analytical chemistry.
[22] Michele Vendruscolo,et al. Metastability of native proteins and the phenomenon of amyloid formation. , 2011, Journal of the American Chemical Society.
[23] Michele Vendruscolo,et al. Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. , 2011, The Journal of chemical physics.
[24] Michele Vendruscolo,et al. Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. , 2011, The Journal of chemical physics.
[25] Brit Mollenhauer,et al. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study , 2011, The Lancet Neurology.
[26] T. Iwatsubo,et al. Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. , 2010, The Journal of biological chemistry.
[27] S. Lindquist,et al. α-Synuclein: membrane interactions and toxicity in Parkinson's disease. , 2010, Annual review of cell and developmental biology.
[28] Michael Wolff,et al. Seeding induced by α‐synuclein oligomers provides evidence for spreading of α‐synuclein pathology , 2009, Journal of neurochemistry.
[29] O. Lindvall,et al. Research in motion: the enigma of Parkinson's disease pathology spread , 2008, Nature Reviews Neuroscience.
[30] T. Jovin,et al. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein. , 2008, Journal of molecular biology.
[31] Elisabet Englund,et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.
[32] B. Jeon,et al. α-Synuclein gene duplication is present in sporadic Parkinson disease , 2008, Neurology.
[33] Kathryn Ziegler-Graham,et al. Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.
[34] David Klenerman,et al. Optimized threshold selection for single-molecule two-color fluorescence coincidence spectroscopy. , 2007, Analytical chemistry.
[35] C. Tanner,et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.
[36] Richard W. Clarke,et al. Determination of the fraction and stoichiometry of femtomolar levels of biomolecular complexes in an excess of monomer using single-molecule, two-color coincidence detection. , 2006, Analytical chemistry.
[37] A. Fink. The Aggregation and Fibrillation of α-Synuclein , 2006 .
[38] C. Dobson,et al. Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.
[39] A. Fink. The aggregation and fibrillation of alpha-synuclein. , 2006, Accounts of chemical research.
[40] N. Bonini,et al. Snaring the Function of α-Synuclein , 2005, Cell.
[41] J. Hardy,et al. Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration. , 2005, Biochemical Society transactions.
[42] N. Bonini,et al. Snaring the function of alpha-synuclein. , 2005, Cell.
[43] C. Dobson. Protein folding and misfolding , 2003, Nature.
[44] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[45] Jie Li,et al. The Association of α-Synuclein with Membranes Affects Bilayer Structure, Stability, and Fibril Formation* , 2003, Journal of Biological Chemistry.
[46] Shu-Bing Qian,et al. Quantitating protein synthesis, degradation, and endogenous antigen processing. , 2003, Immunity.
[47] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[48] A. Singleton,et al. alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.
[49] V. Subramaniam,et al. Dependence of α-synuclein aggregate morphology on solution conditions , 2002 .
[50] V. Subramaniam,et al. Dependence of alpha-synuclein aggregate morphology on solution conditions. , 2002, Journal of molecular biology.
[51] J. George,et al. The synucleins , 2001, Genome Biology.
[52] Liming Ying,et al. Ratiometric Analysis of Single-Molecule Fluorescence Resonance Energy Transfer Using Logical Combinations of Threshold Criteria: A Study of 12-mer DNA , 2000 .
[53] L. Serpell,et al. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[54] Zhang Ming,et al. Bioenergetic and Oxidative Stress in Neurodegenerative Diseases , 2000 .
[55] M. Citron,et al. alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. , 1999, The Journal of biological chemistry.
[56] E. Masliah,et al. Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro , 1999 .
[57] E. Masliah,et al. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. , 1999, Neuroreport.
[58] Nigel J. Cairns,et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.
[59] R A Crowther,et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. , 1998, Neuroscience letters.
[60] P. Lansbury. Structural Neurology: Are Seeds at the Root of Neuronal Degeneration? , 1997, Neuron.
[61] Akihiko Iwai,et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.
[62] Fumio Oosawa,et al. Thermodynamics of the polymerization of protein , 1975 .